Why This Analyst Sees Big Upside in COVID-19 Immunotherapy Study
After Corvus Pharmaceuticals announced that it would initiate an early-stage immunotherapy study in patients with COVID-19, Wedush sees this stock running much higher.
After Corvus Pharmaceuticals announced that it would initiate an early-stage immunotherapy study in patients with COVID-19, Wedush sees this stock running much higher.
Biogen may be on track to be one of the first companies with a meaningful treatment for Alzheimer’s disease, and this could have huge implications for the stock.
According to the Bing COVID-19 Tracker, the number of global cases has reached 11,797,213, after surging 217,376 in the past day. On most days of the past week, the number has been higher by…
Many hospitals shut down elective surgeries and other activities to brace for the impact of COVID-19. However, analysis on these shutdowns is yielding some interesting insight.
A new research report outlines favorable Liquidia Technologies drug study data that will be presented in the coming weeks, which could add up to more than 300% potential upside.
Corvus Pharmaceuticals watched the COVID-19 stock bump play out in Tuesday’s session as this company joins the ever-growing list of coronavirus stocks.
Novavax and Regeneron Pharmaceuticals each made solid progress on Tuesday after each company received a sizable capital injection from the U.S. government’s Operation Warp Speed program.
24/7 Wall Street has picked out a few of the best and brightest coronavirus stocks that could still see a big push as 2020 continues.
According to the Bing COVID-19 Tracker, the number of global cases has reached 11,579,837, after rising 160,308 in the past day. In most days over the past week, the number has been higher by…
According to the Bing COVID-19 Tracker, the number of global cases has reached 11,419,529, a large surge of 326,347. The global increase was the largest on record, according to the World Health Organization. In…
According to the Bing COVID-19 Tracker, the number of global cases has reached 11,037,625, up 163,479, which continues a two-week string of days when the increase per day was almost always above 100,000. The…
According to the Bing COVID-19 Tracker, the number of global cases has reached 10,694,288, a surge of 181,905, a rate much higher than the day prior. The World Health Organization has warned these numbers…
Here is a look of a few of the biggest clinical trial and FDA updates to watch for in July 2020.
Akero Therapeutics has been public for only about a year now, and despite shares surging over 30% to an all-time high in Wednesday’s session, analysts think this stock can go much higher.
Some small companies are destined to be small forever. Others can grow into huge companies over time. What will be the story for Aytu BioScience?